MYCBP and ovarian cancer: HEK293 cells derived exosomes delivered exogenous miR-22 enhanced the radiosensitivity of ovarian cancer by inhibiting the expression of c-MyC binding protein (MYCBP) and human telomerase reverse transcriptase (hTERT) (Konishi et al., 2020).